CIK 0000879169 · Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943136539
- Phone
- 3024986700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,435,748
- in 1 filing, $28.4M under 10b5-1 plans
Net −$28,435,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale 10b5-1 | −35,042 | $116.06 | $4.1M | 236,067 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale 10b5-1 | −22,336 | $117.15 | $2.6M | 213,731 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale 10b5-1 | −60,270 | $118.27 | $7.1M | 153,461 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale 10b5-1 | −73,969 | $119.12 | $8.8M | 79,492 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale 10b5-1 | −48,576 | $119.66 | $5.8M | 30,916 |
Page 1 of 1 · 5 trades